ALKEON CAPITAL MANAGEMENT LLC - 31 Dec 2024 SCHEDULE 13G Report for Keros Therapeutics, Inc. Common Stock, par value $0.0001 per share (KROS)

Filing Manager: ALKEON CAPITAL MANAGEMENT LLC
Reporting Manager: Alkeon Capital Management LLC
Security: Keros Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: KROS
Shares outstanding: 40,777,778 shares
Disclosed Ownership: 1,101,000 shares
Ownership: 2.7%
Form type: SCHEDULE 13G
Filing time: 14 Feb 2025, 16:12:14 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Alkeon Capital Management LLC	2.7%	1,101,000	0	1,101,000	/s/ Jennifer Shufro	Jennifer Shufro, Compliance Officer
Panayotis D. Sparaggis	2.7%	1,101,000	0	1,101,000	/s/ Panayotis D. Sparaggis	Panayotis D. Sparaggis, individually